Janus Henderson Investors US’s Biogen BIIB Stock Holding History

Janus Henderson Investors US’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$530M	Buy	1,936,719 +1,301,251	+205%	+$368M	0.43%	49
2016 Q4	$180M	Sell	635,468 -14,130	-2%	-$4.19M	0.15%	187
2016 Q3	$203M	Sell	649,598 -153,759	-19%	-$45.5M	0.17%	172
2016 Q2	$194M	Sell	803,357 -94,703	-11%	-$25M	0.17%	176
2016 Q1	$234M	Sell	898,060 -89,123	-9%	-$23.5M	0.2%	128
2015 Q4	$302M	Sell	987,183 -1,017,617	-51%	-$292M	0.26%	94
2015 Q3	$585M	Sell	2,004,800 -214,710	-10%	-$70.9M	0.52%	33
2015 Q2	$896M	Buy	2,219,510 +39,233	+2%	+$15.7M	0.74%	23
2015 Q1	$921M	Sell	2,180,277 -499,445	-19%	-$197M	0.76%	19
2014 Q4	$910M	Buy	2,679,722 +404,124	+18%	+$131M	0.78%	16
2014 Q3	$753M	Sell	2,275,598 -31,053	-1%	-$10.2M	0.69%	26
2014 Q2	$726M	Buy	2,306,651 +95,271	+4%	+$28.7M	0.67%	31
2014 Q1	$676M	Buy	2,211,380 +809,076	+58%	+$257M	0.63%	33
2013 Q4	$392M	Buy	1,402,304 +338,946	+32%	+$87.7M	0.37%	66
2013 Q3	$256M	Buy	1,063,358 +249,748	+31%	+$55.9M	0.25%	110
2013 Q2	$175M	Buy	+813,610	New	+$174M	0.18%	146

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Investors US's BIIB Position: Q1 2017 in Review

Janus Henderson Investors US increased its Biogen (BIIB) stake by 205% in Q1 2017, buying an estimated $368M and bringing the position to 1,936,719 shares worth $530M. The position accounts for 0.43% of the portfolio, ranked #49.

Janus Henderson Investors US first reported a position in BIIB in Q2 2013 and has held it in 16 quarters since. The position peaked at $921M in Q1 2015. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

Janus Henderson Investors US held 1,936,719 shares of Biogen worth $530M as of Q1 2017.
Janus Henderson Investors US bought 1,301,251 Biogen shares in Q1 2017, an estimated $368M.
Biogen made up 0.43% of Janus Henderson Investors US's portfolio in Q1 2017, its #49 holding.
Janus Henderson Investors US first reported a position in Biogen in Q2 2013 and has held it in 16 quarters since.
Janus Henderson Investors US's Biogen position peaked at $921M in Q1 2015.
1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.